Adaptimmune Therapeutics plc (NASDAQ:ADAP) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) have been assigned an average rating of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have assigned a buy recommendation to […]
Shares of Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) have been assigned an average rating of “Hold” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have assigned a buy recommendation to […]
